Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 103-108

  Benoit, Audrey ^a,b   Bodnar, Michael ^a,c   Malla, Ashok K ^a,c   Joober, Ridha ^a,c   Bherer, Louis ^d   Lepage, Martin ^a,b,c  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

Cognitive marker; First episode psychosis; Longitudinal; Remission; Verbal memory

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NON REMITTED FIRST EPISODE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOSIS; REMITTED FIRST EPISODE PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; TREATMENT DURATION; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; COMPLICATION; CROSS-SECTIONAL STUDY; FOLLOW UP; LEARNING; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RECURRENT DISEASE; TIME; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS, NONPARAMETRIC; TIME FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 84895800514     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.024     Document Type: Article

References (40)

1. Addington J., Saeedi H., Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr. Res. 2005, 78(1):35-43.
2. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005, 162(3):441-449.
3. August S.M., Kiwanuka J.N., McMahon R.P., Gold J.M. The MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlates. Schizophr. Res. 2012, 134(1):76-82.
4. Bodnar M., Malla A., Joober R., Lepage M. Cognitive markers of short-term clinical outcome in first-episode psychosis. Br. J. Psychiatry 2008, 193(4):297-304.
5. Bodnar M., Malla A.K., Czechowska Y., Benoit A., Fathalli F., Joober R., Pruessner M., Pruessner J., Lepage M. Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. Schizophr. Res. 2010, 122(1-3):72-80.
6. Bodnar M., Harvey P.-O., Malla A.K., Joober R., Lepage M. The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. Clin. Schizophr. Relat. Psychoses 2011, 4(4):217-228.
7. Bodnar M., Achim A.M., Malla A.K., Joober R., Benoit A., Lepage M. Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br. J. Psychiatry J. Ment. Sci. 2012, 200(4):300-307.
8. Bodnar M., Malla A.K., Joober R., Lord C., Smith E., Pruessner J., Lepage M. Neural markers of early remission in first-episode schizophrenia: a volumetric neuroimaging study of the parahippocampus. Psychiatry Res. 2012, 201(1):40-47.
9. Bozikas V.P., Andreou C. Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust. N. Z. J. Psychiatry 2011, 45(2):93-108.
10. Brissos S., Dias V.V., Balanza-Martinez V., Carita A.I., Figueira M.L. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr. Res. 2011, 129(2-3):133-136.
11. Cassidy C.M., Norman R., Manchanda R., Schmitz N., Malla A. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2years. Schizophr. Bull. 2010, 36(5):1001-1008.
12. Ciudad A., Alvarez E., Bobes J., San L., Polavieja P., Gilaberte I. Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophr. Res. 2009, 108(1-3):214-222.
13. Dominguez Mde G., Viechtbauer W., Simons C.J., van Os J., Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol. Bull. 2009, 135(1):157-171.
14. Eberhard J., Levander S., Lindstrom E. Remission in schizophrenia: analysis in a naturalistic setting. Compr. Psychiatry 2009, 50(3):200-208.
15. Emsley R., Oosthuizen P., Koen L., Niehaus D.J., Medori R., Rabinowitz J. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int. Clin. Psychopharmacol. 2008, 23(6):325-331.
16. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P & SCID-I/NP), Version 2 1998, New York Psychiatric Institute, Biometrics Research, New York.
17. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiatr. Res. 2006, 40(8):738-745.
18. Hofer A., Bodner T., Kaufmann A., Kemmler G., Mattarei U., Pfaffenberger N.M., Rettenbacher M.A., Trebo E., Yalcin N., Fleischhacker W.W. Symptomatic remission and neurocognitive functioning in patients with schizophrenia. Psychol. Med. 2011, 41(10):2131-2139.
19. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry 1999, 156(9):1336-1341.
20. Hollingshead A. Two-Factor Index of Social Position 1965, Yale University Press, New Haven, CN.
21. Jensen B., Regier L.D. Drug Comparison Charts. RxFiles Academic Detailing Program, Saskatoon, Saskatchewan 2010, 118. 8th edition.
22. Kay S., Fiszbein A., Opler L. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
23. Keshavan M.S., Schooler N.R. First-episode studies in schizophrenia: criteria and characterization. Schizophr. Bull. 1992, 18(3):491-513.
24. Li C.T., Su T.P., Chou Y.H., Lee Y.C., Liu M.E., Ku H.L., Shan I.K., Bai Y.M. Symptomatic resolution among Chinese patients with schizophrenia and associated factors. J. Formos. Med. Assoc. 2010, 109(5):378-388.
25. Luck D., Buchy L., Czechowska Y., Bodnar M., Pike G.B., Campbell J.S., Achim A., Malla A., Joober R., Lepage M. Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J. Psychiatr. Res. 2011, 45(3):369-377.
26. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust. N. Z. J. Psychiatry 2003, 37(4):407-413.
27. Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., Haricharan R. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol. Med. 2006, 36(5):649-658.
28. Meesters P.D., Comijs H.C., de Haan L., Smit J.H., Eikelenboom P., Beekman A.T., Stek M.L. Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia. Schizophr. Res. 2011, 126(1-3):237-244.
29. Meesters P.D., Schouws S., Stek M., de Haan L., Smit J., Eikelenboom P., Beekman A., Comijs H. Cognitive impairment in late life schizophrenia and bipolar I disorder. Int. J. Geriatr. Psychiatry 2013, 28(1):82-90.
30. Montreuil T., Bodnar M., Bertrand M.C., Malla A.K., Joober R., Lepage M. Social cognitive markers of short-term clinical outcome in first-episode psychosis. Clin. Schizophr. Relat. Psychoses 2010, 4(2):105-114.
31. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72(1):29-39.
32. Oorschot M., Lataster T., Thewissen V., Lardinois M., van Os J., Delespaul P.A., Myin-Germeys I. Symptomatic remission in psychosis and real-life functioning. Br. J. Psychiatry J. Ment. Sci. 2012, 201(3):215-220.
33. Rund B.R., Melle I., Friis S., Johannessen J.O., Larsen T.K., Midbøe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr. Res. 2007, 91(1-3):132-140.
34. Seaton B.E., Goldstein G., Allen D.N. Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning. Neuropsychol. Rev. 2001, 11(1):45-67.
35. Ventura J., Subotnik K.L., Guzik L.H., Hellemann G.S., Gitlin M.J., Wood R.C., Nuechterlein K.H. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophr. Res. 2011, 132(1):18-23.
36. Verdoux H., Liraud F., Assens F., Abalan F., van Os J. Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophr. Res. 2002, 56(1-2):149-159.
37. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio, TX. 3rd ed.
38. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, New York. 3rd ed.
39. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64(6):663-667.
40. Yun da Y., Hwang S.S., Kim Y., Lee Y.H., Kim Y.S., Jung H.Y. Impairments in executive functioning in patients with remitted and non-remitted schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(4):1148-1154.